Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Net Margin: 2014-2020

Historic Net Margin for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to 1,198.01%.

  • Larimar Therapeutics' Net Margin fell 142899.00% to 1,198.01% in Q1 2020 from the same period last year, while for Mar 2020 it was 2,291.13%, marking a year-over-year decrease of 72676.00%. This contributed to the annual value of 2,572.54% for FY2019, which is 64827.00% down from last year.
  • Latest data reveals that Larimar Therapeutics reported Net Margin of 1,198.01% as of Q1 2020, which was down 40.66% from 2,018.78% recorded in Q4 2019.
  • Larimar Therapeutics' Net Margin's 5-year high stood at 163,562.50% during Q4 2017, with a 5-year trough of 1,198.01% in Q1 2020.
  • Its 3-year average for Net Margin is 2,706.80%, with a median of 2,919.84% in 2018.
  • In the last 5 years, Larimar Therapeutics' Net Margin surged by 15,280,064bps in 2017 and then crashed by 16,064,266bps in 2018.
  • Larimar Therapeutics' Net Margin (Quarterly) stood at 10,761.86% in 2016, then spiked by 15,280,064bps to 163,562.50% in 2017, then slumped by 16,064,266bps to 2,919.84% in 2018, then plummeted by 90,106bps to 2,018.78% in 2019, then slumped by 142,899bps to 1,198.01% in 2020.
  • Its Net Margin stands at 1,198.01% for Q1 2020, versus 2,018.78% for Q4 2019 and 3,023.71% for Q3 2019.